NYNRIN
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| NYN domain and retroviral integrase containing | Ensembl:ENSG00000205978 | HGNC:HGNC:20165 | PA165479228 | 14q12 |
GO terms in NYNRIN
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | ND | GO:0008150 | biological_process |
| BP | IEA | GO:0015074 | DNA integration |
| CC | ND | GO:0005575 | cellular_component |
| CC | IEA | GO:0016021 | integral component of membrane |
| MF | ND | GO:0003674 | molecular_function |
| MF | IEA | GO:0003676 | nucleic acid binding |
Gene expression in normal tissue: NYNRIN
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NYNRIN
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD193 | Fqi1 | 7 |
| iGMDRD61 | Kinetin riboside | 6 |
| iGMDRD297 | Austocystin D | 2 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD679 | Bistramide A | 4 |
| iGMDRD554 | CHEMBL1434137 | 3 |
| iGMDRD151 | CHM-1 | 3 |
| iGMDRD387 | CHIR-99021 | 1 |
| iGMDRD599 | Salermide | 3 |
| iGMDRD420 | Leucascandrolide A | 3 |
| iGMDRD144 | NSC95397 | 4 |
| iGMDRD779 | PRL-3 Inhibitor I | 1 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD188 | Piperlongumine | 4 |
| iGMDRD577 | BIX01294 | 3 |
| iGMDRD506 | Fedratinib | 2 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD60 | Quinoclamine | 4 |
| iGMDRD64 | Parbendazole | 6 |
| iGMDRD524 | ISX-9 | 2 |
| iGMDRD255 | SB225002 | 7 |
| iGMDRD260 | FQI-2 | 3 |
| iGMDRD782 | DC-45-A2 | 3 |
| iGMDRD885 | Compound 110 | 2 |
| iGMDRD318 | PAC-1 | 12 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD187 | BRD9876 | 5 |
| iGMDRD52 | Rotenone | 9 |
| iGMDRD351 | GW843682X | 8 |
| iGMDRD237 | ABT-751 | 5 |
| iGMDRD901 | ELCPK | 7 |
| iGMDRD123 | Isoevodiamine | 5 |
| iGMDRD84 | Lovastatin acid | 5 |
| iGMDRD330 | BRD4132 | 1 |
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD607 | Ubistatin B | 3 |
| iGMDRD150 | RITA | 2 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD79 | Gemcitabine | 1 |
| iGMDRD871 | BRD6368 | 4 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD872 | BRD7137 | 7 |
| iGMDRD329 | Merck60 | 2 |
| iGMDRD366 | PI-103 | 3 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD300 | Tozasertib | 6 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD42 | Vorinostat | 3 |
| iGMDRD322 | FK 866 | 2 |
| iGMDRD121 | GMX1778 | 4 |
| iGMDRD227 | Fatostatin A | 2 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD105 | Triptolide | 2 |
| iGMDRD434 | BMS-536924 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NYNRIN
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.